Literature DB >> 28862748

Inflammasome-mediated inflammation and fibrosis: It is more than just the IL-1β.

Muhammad Amir1, Mark J Czaja1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28862748      PMCID： PMC5832548          DOI： 10.1002/hep.29491

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  9 in total

1.  Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice.

Authors:  Kouichi Miura; Yuzo Kodama; Sayaka Inokuchi; Bernd Schnabl; Tomonori Aoyama; Hirohide Ohnishi; Jerrold M Olefsky; David A Brenner; Ekihiro Seki
Journal:  Gastroenterology       Date:  2010-03-27       Impact factor: 22.682

Review 2.  Sterile inflammation in the liver.

Authors:  Paul Kubes; Wajahat Z Mehal
Journal:  Gastroenterology       Date:  2012-09-13       Impact factor: 22.682

Review 3.  Inflammasomes in Liver Fibrosis.

Authors:  Fernando Alegre; Pablo Pelegrin; Ariel E Feldstein
Journal:  Semin Liver Dis       Date:  2017-05-31       Impact factor: 6.115

4.  NLRP3 inflammasome driven liver injury and fibrosis: Roles of IL-17 and TNF in mice.

Authors:  Alexander Wree; Matthew D McGeough; Maria Eugenia Inzaugarat; Akiko Eguchi; Susanne Schuster; Casey D Johnson; Carla A Peña; Lukas J Geisler; Bettina G Papouchado; Hal M Hoffman; Ariel E Feldstein
Journal:  Hepatology       Date:  2017-12-28       Impact factor: 17.425

5.  Toll-like receptor 2 and palmitic acid cooperatively contribute to the development of nonalcoholic steatohepatitis through inflammasome activation in mice.

Authors:  Kouichi Miura; Ling Yang; Nico van Rooijen; David A Brenner; Hirohide Ohnishi; Ekihiro Seki
Journal:  Hepatology       Date:  2013-02       Impact factor: 17.425

Review 6.  Inflammasome activation and function in liver disease.

Authors:  Gyongyi Szabo; Jan Petrasek
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-06-09       Impact factor: 46.802

7.  NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice.

Authors:  Alexander Wree; Akiko Eguchi; Matthew D McGeough; Carla A Pena; Casey D Johnson; Ali Canbay; Hal M Hoffman; Ariel E Feldstein
Journal:  Hepatology       Date:  2014-01-30       Impact factor: 17.425

8.  Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice.

Authors:  Jean-Philippe Pradere; Johannes Kluwe; Samuele De Minicis; Jing-Jing Jiao; Geum-Youn Gwak; Dianne H Dapito; Myoung-Kuk Jang; Nina D Guenther; Ingmar Mederacke; Richard Friedman; Ana-Cristina Dragomir; Costica Aloman; Robert F Schwabe
Journal:  Hepatology       Date:  2013-08-09       Impact factor: 17.425

Review 9.  Role of NLRP3 Inflammasome in the Progression of NAFLD to NASH.

Authors:  Xingyong Wan; Chengfu Xu; Chaohui Yu; Youming Li
Journal:  Can J Gastroenterol Hepatol       Date:  2016-05-04
  9 in total
  5 in total

1.  14-Deoxygarcinol improves insulin sensitivity in high-fat diet-induced obese mice via mitigating NF-κB/Sirtuin 2-NLRP3-mediated adipose tissue remodeling.

Authors:  Jia-Li Chen; Zhe-Ling Feng; Fei Zhou; Ruo-Han Lou; Cheng Peng; Yang Ye; Li-Gen Lin
Journal:  Acta Pharmacol Sin       Date:  2022-08-09       Impact factor: 7.169

2.  Stem Cells From Human Exfoliated Deciduous Teeth Alleviate Liver Cirrhosis via Inhibition of Gasdermin D-Executed Hepatocyte Pyroptosis.

Authors:  Peng Chen; Yi-Kun Zhou; Chun-Shan Han; Liu-Jing Chen; Yi-Ming Wang; Zi-Meng Zhuang; Shuai Lin; Yan-Heng Zhou; Jiu-Hui Jiang; Rui-Li Yang
Journal:  Front Immunol       Date:  2022-05-12       Impact factor: 8.786

Review 3.  The Crucial Role of NLRP3 Inflammasome in Viral Infection-Associated Fibrosing Interstitial Lung Diseases.

Authors:  Wiwin Is Effendi; Tatsuya Nagano
Journal:  Int J Mol Sci       Date:  2021-09-28       Impact factor: 5.923

Review 4.  Inflammasomes and Fibrosis.

Authors:  Wen-Juan Zhang; Shu-Juan Chen; Shun-Chang Zhou; Su-Zhen Wu; Hui Wang
Journal:  Front Immunol       Date:  2021-06-11       Impact factor: 7.561

5.  Calcipotriol Inhibits NLRP3 Signal Through YAP1 Activation to Alleviate Cholestatic Liver Injury and Fibrosis.

Authors:  Xiaopeng Wang; Guiyang Wang; Junwen Qu; Zhiqing Yuan; Ruogu Pan; Kewei Li
Journal:  Front Pharmacol       Date:  2020-03-31       Impact factor: 5.810
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.